Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 5/20 | 0.45 |
| ▸ | PI4K2B | Q8TCG2 | 5/20 | 0.45 |
| ▸ | PI4K2A | Q9BTU6 | 5/20 | 0.45 |
| ▸ | PI4KB | Q9UBF8 | 5/20 | 0.45 |
| ▸ | XDH | P47989 | 2/20 | 0.45 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.38 |
| ▸ | RET | P07949 | 1/20 | 0.36 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.36 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.36 |
| ▸ | AHCY | P23526 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | PNP | P00491 | 1/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL3414603 | 0.96 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL3416954 | 0.96 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL3413247 | 0.96 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL8110 | 0.96 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL1871837 | 0.94 | PI4KA (0.44) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL2895675 | 0.93 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL1370888 | 0.93 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL20485928 | 0.93 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL10868999 | 0.93 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBXDH | |
| Adenine SCHEMBL11798390 | 0.93 | PI4KA (0.50) | PI4KAPI4K2BPI4K2API4KBXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150231177-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2015-08-20 | — | — | US | claimed |
| US-20120207793-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2012-08-16 | — | — | US | claimed |
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | claimed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | claimed |
| US-20090169630-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2009-07-02 | — | — | US | claimed |
| EP-2024287-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | Virginia Commonwealth University (US) | 2009-02-18 | — | — | EP | claimed |
| WO-2007134304-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-11-22 | — | — | WO | claimed |
| US-20150231177-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2015-08-20 | — | — | US | disclosed |
| US-20130289471-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2013-10-31 | — | — | US | disclosed |
| US-20120207793-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2012-08-16 | — | — | US | disclosed |
| US-20120184898-A1 | GAS BASED WOUND AND TISSUE THERAPEUTICS | TENAX THERAPEUTICS, INC | 2012-07-19 | — | — | US | disclosed |
| US-8101117-B2 | Controlled gas pore formers in extruded ware | CORNING, INCORPORATED (US) | 2012-01-24 | — | — | US | disclosed |
| EP-2252333-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | Oxygen Biotherapeutics, Inc. (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20090298667-A1 | Controlled Gas Pore Formers in Extruded Ware | CORNING INCORPORATED | 2009-12-03 | — | — | US | disclosed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | disclosed |
| US-20090202617-A1 | Gas based wound and tissue therapeutics | TENAX THERAPEUTICS, INC | 2009-08-13 | — | — | US | disclosed |
| US-20090169630-A1 | Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications | VIRGINIA COMMONWEALTH UNIVERSITY | 2009-07-02 | — | — | US | disclosed |
| EP-2024287-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | Virginia Commonwealth University (US) | 2009-02-18 | — | — | EP | disclosed |
| WO-2009006586-A2 | SELF-CONTAINED OXYGEN GENERATING AND BREATHING SYSTEMS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2009-01-08 | — | — | WO | disclosed |
| WO-2007134304-A1 | METHODS AND COMPOSITIONS FOR CONTROLLED AND SUSTAINED PRODUCTION AND DELIVERY OF PEROXIDES | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202617-A1 | Gas based wound and tissue therapeutics | PGF, FGF2, FGF1 | PI4KA 3364/4885PI4K2B 3323/4885PI4K2A 3689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.